Common Equity: The sum of all common equity items.
MAIA Biotechnology, Inc. (MAIA) had Common Equity of $2.38M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.63M |
|
-- |
|
-- |
|
$4.32M |
|
$-4.32M |
|
$0.69M |
|
$-3.63M |
|
$-3.63M |
|
$-3.63M |
|
$-3.63M |
|
$-3.63M |
|
$-3.63M |
|
$-4.32M |
|
$-4.32M |
|
32.12M |
|
32.12M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$9.70M |
|
-- |
|
$0.00M |
|
$9.70M |
|
$5.84M |
|
-- |
|
$1.49M |
|
$7.33M |
|
|
Common Equity |
$2.38M |
$2.38M |
|
$2.38M |
|
38.62M |
|
| Cash Flow Statement Financials | |
$-18.84M |
|
-- |
|
$17.91M |
|
$9.60M |
|
$8.66M |
|
$-0.94M |
|
$2.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-152.73% |
|
-152.73% |
|
-37.39% |
|
-152.73% |
|
$0.06 |
|
$-0.59 |
|
$-0.59 |
|